Effectiveness and safety of Ustekinumab in patients with inflammatory bowel disease from the real-world study: A systematic review with meta-analysis of observational studies

被引:0
|
作者
Zhou, He [1 ]
Wang, Fang [1 ]
Su, Song [1 ]
Shi, Yanting [1 ]
Wu, Tong [1 ]
Liang, Jie [1 ]
机构
[1] Air Force Mil Med Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
关键词
inflammatory bowel disease; biologics; effectiveness; meta-analysis; real-world; ustekinumab;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
0472
引用
收藏
页码:88 / 88
页数:1
相关论文
共 50 条
  • [41] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Brian Bressler
    Jennifer Jones
    Tracy S. H. In
    Tommy Lan
    Cristian Iconaru
    John K. Marshall
    [J]. Advances in Therapy, 2023, 40 : 4421 - 4439
  • [42] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Bressler, Brian
    Jones, Jennifer
    In, Tracy S. H.
    Lan, Tommy
    Iconaru, Cristian
    Marshall, John K.
    [J]. ADVANCES IN THERAPY, 2023, 40 (10) : 4421 - 4439
  • [43] Effectiveness and safety of Ustekinumab for the treatment of Crohn's disease in real-life experiences: a meta-analysis of observational studies
    Macaluso, Fabio Salvatore
    Maida, Marcello
    Ventimiglia, Marco
    Cottone, Mario
    Orlando, Ambrogio
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (02) : 193 - 203
  • [44] Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis
    Godoy Brewer, Gala M.
    Salem, George
    Afzal, Muhammad A.
    Limketkai, Berkeley N.
    Haq, Zadid
    Tajamal, Maryam
    Melia, Joanna
    Lazarev, Mark
    Selaru, Florin M.
    Parian, Alyssa M.
    [J]. BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [45] Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentre Real-World Observational Study
    Parra, R.
    Chebli, J. M. F.
    de Azevedo, M. Freitas Cardoso
    Chebli, L. A.
    Zabot, G. P.
    Cassol, O. S.
    Froes, R. D. S. B.
    Santana, G. O.
    Lubini, M.
    Magro, D. O.
    Imbrizi, M.
    Moraes, A. C. S.
    Teixeira, F. V.
    Alves, A. J. T., Jr.
    Gasparetti Junior, N. L. T.
    Ferreira, S. D. C.
    Queiroz, N. S. F.
    Kotze, P. G.
    Feres, O.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1311 - I1311
  • [46] REAL-WORLD EFFECTIVENESS AND SAFETY OF TEDUGLUTIDE IN ADULT SHORT BOWEL SYNDROME: A META-ANALYSIS
    Paski, Shirley
    Raphael, Bram P.
    Ronveaux, Charlotte
    Jiang, Jeanne
    Ursos, Lyann
    Uddin, Sharif M.
    Iyer, Kishore R.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S741 - S741
  • [47] Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn's Disease Patients
    Garg, Rajat
    Aggarwal, Manik
    Butler, Robert
    Achkar, Jean Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Qazi, Taha
    Rieder, Florian
    Regueiro, Miguel
    Click, Benjamin
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) : 3138 - 3147
  • [48] Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients
    Rajat Garg
    Manik Aggarwal
    Robert Butler
    Jean Paul Achkar
    Bret Lashner
    Jessica Philpott
    Benjamin Cohen
    Taha Qazi
    Florian Rieder
    Miguel Regueiro
    Benjamin Click
    [J]. Digestive Diseases and Sciences, 2022, 67 : 3138 - 3147
  • [49] Effectiveness and safety of ustekinumab in patients with Crohn's disease: a real-world experience
    Mohammad, D.
    Alshahrani, A.
    Bao, Y.
    Alramdan, R.
    Rajani, A.
    Chauhan, U.
    Salena, B.
    Tse, F.
    Greenwald, E.
    Albashir, S.
    Halder, S.
    Armstrong, D.
    Marshall, J.
    Narula, N.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S426 - S426
  • [50] Effectiveness and safety of pegvisomant: a systematic review and meta-analysis of observational longitudinal studies
    Leonart, Leticia P.
    Tonin, Fernanda S.
    Ferreira, Vinicius L.
    Fernandez-Llimos, Fernando
    Pontarolo, Roberto
    [J]. ENDOCRINE, 2019, 63 (01) : 18 - 26